Enhanced Th17 phenotype in uninfected neonates born from viremic HIV-1-infected pregnant women

Journal of Clinical Immunology

Volumn 31, Issue 2, 2011, Pages 186-194

  Hygino, Joana ^a   Vieira, Morgana M ^a   Guillermo, Landi V ^a   Silva Filho, Renato G ^a   Saramago, Carmen ^a   Lima Silva, Agostinho A ^a   Andrade, Regis M ^a   Andrade, Arnaldao F B ^b   Brindeiro, Rodrigo M ^c   Tanuri, Amilcar ^c   Guimarães, Vander ^d   De Melo Bento, Cleonice Alves ^a  

^a FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

cytokines; HIV; IL 10 and IL 17; neonates; pregnant women

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MONOCYTE; NEWBORN; PREGNANT WOMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; UMBILICAL CORD BLOOD; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ADULT; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FEMALE; FETAL BLOOD; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT, NEWBORN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; PREGNANCY; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS; YOUNG ADULT;

EID: 79959760770     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9485-3     Document Type: Article

References (43)

1. Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of pediatric HIV infection. Lancet. 2000;7370:68-80.
2. Meyer UJ, Schedlowski M, Yee BK. Immunological stress at the maternal - foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun. 2006;20:378-88. (Pubitemid 43775782)
3. Duke T. Neonatal pneumonia in developing countries. Arch Dis Child Fetal Neonatal. 2005;90:F211-9.
4. Disease BB. Outcomes as a consequence of environmental influences on the development of the immune system. Curr Opin Allergy Clin Immun. 2007;9:185-9.
5. Sodora DL, Silvestri G. Immune activation and AIDS pathogenesis. AIDS. 2008;22:439-46. (Pubitemid 351317285)
6. Chaouat G. The Th1/Th2 paradigm: still important in pregnancy? Semin Immunopathol. 2007;29:95-113.
7. Saito S, Shiozaki A, Sasak Y, Nakashima A, Shima T, Ito M. Regulatory T cells and regulatory natural killer (NK) cells play important roles in feto-maternal tolerance. Semin Immunopathol. 2007;29:115-22. (Pubitemid 47596391)
8. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol. 2004;5:266-71. (Pubitemid 38332123)
9. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28-50. (Pubitemid 44116698)
10. Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion. Mol Hum Reprod. 2004;10:347-53. (Pubitemid 38714366)
11. Piazza F, Astori MG, Maccabruni A, Caselli D, Bossi G, Lanzi G. Neuropsychological development of children born to HIV-positive mothers. Pediatr Med Chir. 1995;17:331-3.
12. Piccini PM. T cells in normal pregnancy and recurrent pregnancy loss. Reprod Biomed. 2006;13:840-4.
13. Wilczynski JR. Immunological analogy between allograft rejection, recurrent abortion and pre-eclampsia-the same basic mechanism? Hum Immunol. 2006;67:492-511.
14. Sayed Zaki E, Goda H. Relevance of parvovirus B19, herpes simplex virus 2, and cytomegalovirus virologic markers in maternal serum for diagnosis of unexplained recurrent abortions. Arch Pathol Lab Med. 2007;131:956-60. (Pubitemid 46906390)
15. Huppertz B. The feto-maternal interface: setting the stage for potential immune interactions. Semin Immunopathol. 2007;29:83-94. (Pubitemid 47596393)
16. Lambropoulou M, Tamiolakis D, Venizelos J, Liberis V, Galazios G, Tsikouras P, et al. Imbalance of mononuclear cell infiltrates in the placental tissue from foetuses after spontaneous abortion versus therapeutic termination from 8th to 12th weeks of gestational age. Clin Exp Med. 2006;6:171-6. (Pubitemid 46028479)
17. Shimada S, Nishida R, Takeda M, Iwabuchi K, Kiski R, Onoe K, et al. Natural killer, natural killer T, helper and cytotoxic T cells in the deciduas from sporadic miscarriage. Am J Reprod Immunol. 2006;56:193-200. (Pubitemid 44151493)
18. Jordan JA, Huff D, Deloia JA. Placental cellular immune response in women infected with human parvovirus b19 during pregnancy. Clin Diag Lab Immunol. 2001;8:288-92. (Pubitemid 32217058)
19. Strunk T, Burgner D. Genetic susceptibility to neonatal infection. Curr Opin Infec Dis. 2006;19:259-63. (Pubitemid 43740364)
20. Rautava S, Ruuskanen O, Ouwehand A, Salminen S, Isolauri E. The hygiene hypothesis of atopic disease-an extended version. J Pediatr Gastroenterol Nutr. 2004;38:378-88.
21. Lewis DB, Gern JE, Hill HR, Friedlander SL, La Pine TR, Lemanske RF, et al. Newborn immunology: relevance to the clinician. Curr Probl Pediatr Adolesc Health Care. 2006;36:189-204.
22. Maródi L. Innate cellular immune responses in newborns. Clin Immunol. 2006;118:137-44. (Pubitemid 43199650)
23. Velilla PA, Rugeles MT, Chougnet CA. Defective antigen presenting cell function in human neonates. Clin Immunol. 2006;121:251-9. (Pubitemid 44768008)
24. Willems F, Vollstedt S, Suter M. Phenotype and function of neonatal DC. Eur J Immunol. 2006;39:26-35.
25. Miles S, Balden E, Magpantay L, Wei L, Leiblein A, Hofheinz D, et al. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N Engl J Med. 1993;328:297-302. (Pubitemid 23035327)
26. Kuhn L, Coutsoudis A, Moodley D, Trabattoni D, Mngqundaniso N, Shearer GM, et al. Thelper cell responses to HIV envelope peptides in cord blood: protection against intrapartum and breast-feeding transmission. AIDS. 2001;5:1-9. (Pubitemid 32055773)
27. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. 2000;96:3866-71.
28. Matsuzaki G, Umemura M. IL-17 as an effector molecule of innate and acquired immunity against infectious. Microbiol Immunol. 2007;51:1139-47.
29. Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest. 2007;117:1119-27. (Pubitemid 46718396)
30. McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, Poles M, et al. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. JAIDS. 2004;37:1228-36. (Pubitemid 39281503)
31. Resino S, Bellón JM, Sánchez-Ramón S, Gurbindo D, Muñóz-Fernandez MA. Clinical relevance of cytokine production in HIV- 1 infection in children on antiretroviral therapy. Scand J Immunol. 2000;52:634-40. (Pubitemid 32011779)
32. Bento CAM, Hygino J, Andrade RM, Saramago CSM, Silva RG, Silva AAL, et al. IL-10-secreting T cells from HIV-infected pregnant women down-regulate HIV-1 replication: effect enhanced by anti-retroviral treatment. AIDS. 2009;23:9-18.
33. Hygino J, Lima PG, Filho RGS, Silva AAL, Saramago CSM, Andrade RM, et al. Immunological reactivity in HIV-1-exposed uninfected neonates. Clin Immunol. 2008;127:340-7.
34. Kuhn L, Kasonde P, Sinkala M, Kankasa C, Semrau K, Scott N, et al. Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? Clin Infect Dis. 2005;41:1654-61.
35. Shapiro RL, Lockman S, Kim S, Smeaton L, Rahkola JT, Thior I, et al. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis. 2007;196:562-9. (Pubitemid 47206103)
36. Mussi-Pinhata MM, Freimanis L, Yamamoto AY, Korelitz J, Pinto JA, Cruz ML, et al. Infectious disease morbidity among young HIV-1-exposed but uninfected infants in Latin American and Caribbean countries: the National Institute of Child Health and Human Development International Site Development Initiative Perinatal Study. Pediatrics. 2007;119:e694-704.
37. Jeena PM, Coovadia HM, Thul SA, Blythe D, Buckels NJ, Chetty R. Persistent and chronic lung disease in HIV-1 infected and uninfected African children. AIDS. 1998;12:1185-93. (Pubitemid 28302421)
38. Bingold TM, Ziesché E, Scheller B, Sadik CD, Franck K, Just L, Sartorius S, Wahrmann M, Wissing H, Zwissler B, Pfeilschifter J, Mühl H. IL-22 detected in patient with abdominal sepsis. Schock 2010; 9 (in press).
39. Bozza FA, Salluh JL, Japiassu AM, Soares M, Assis EF, Gomes NR, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care. 2007;11:R49.
40. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity. 2008;28:454-67. (Pubitemid 351471762)
41. Segal BM. Th17 cells in autoimmune demyelinating diseases. Semin Immunopathol. 2010;32:71-7.
42. Lubberts E. Th17 cytokines and arthritis. Semin Immunopathol. 2010;32:43-53.
43. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009;157:209-25.